Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srijan Chatterjee

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 27, 2023
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariantsManojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, et al.
Molecular Therapy. Nucleic Acids|March 20, 2023
Can the RBD mutation R346X provide an additional fitness to the "variant soup," including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy. Nucleic Acids|July 3, 2023
Molnupiravir's mechanism of action drives "error catastrophe" in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virusSrijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Reviews in Medical Virology|September 17, 2024
Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical PerspectivesSrijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, et al.
Vaccine|December 10, 2025
Machine learning (ML) and deep learning (DL) in vaccine target selection, design, development and characterizationManojit Bhattacharya, Srijan Chatterjee, Arpita Das, et al.
Vaccines|October 27, 2022
Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical PerspectiveManojit Bhattacharya, Srijan Chatterjee, Bidyut Mallik, et al.
Journal of Experimental Orthopaedics|December 1, 2023
ChatGPT and large language models in orthopedics: from education and surgery to researchSrijan Chatterjee, Manojit Bhattacharya, Soumen Pal, et al.
Aging and Disease|October 10, 2023
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for SarcopeniaAshish Ranjan Sharma, Srijan Chatterjee, Yeon-Hee Lee, et al.
Molecular Therapy. Nucleic Acids|October 8, 2024
Large language model to multimodal large language model: A journey to shape the biological macromolecules to biological sciences and medicineManojit Bhattacharya, Soumen Pal, Srijan Chatterjee, et al.
Folia Microbiologica|August 12, 2022
Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscapeManojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 27, 2023
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariantsManojit Bhattacharya, Srijan Chatterjee, Sang-Soo Lee, et al.
Molecular Therapy. Nucleic Acids|March 20, 2023
Can the RBD mutation R346X provide an additional fitness to the "variant soup," including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy. Nucleic Acids|July 3, 2023
Molnupiravir's mechanism of action drives "error catastrophe" in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virusSrijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Reviews in Medical Virology|September 17, 2024
Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical PerspectivesSrijan Chatterjee, Manojit Bhattacharya, Sanskriti Saxena, et al.
Vaccine|December 10, 2025
Machine learning (ML) and deep learning (DL) in vaccine target selection, design, development and characterizationManojit Bhattacharya, Srijan Chatterjee, Arpita Das, et al.
Vaccines|October 27, 2022
Therapeutic Role of Neutralizing Antibody for the Treatment against SARS-CoV-2 and Its Emerging Variants: A Clinical and Pre-Clinical PerspectiveManojit Bhattacharya, Srijan Chatterjee, Bidyut Mallik, et al.
Journal of Experimental Orthopaedics|December 1, 2023
ChatGPT and large language models in orthopedics: from education and surgery to researchSrijan Chatterjee, Manojit Bhattacharya, Soumen Pal, et al.
Aging and Disease|October 10, 2023
Targeting Crosstalk of Signaling Pathways among Muscles-Bone-Adipose Tissue: A Promising Therapeutic Approach for SarcopeniaAshish Ranjan Sharma, Srijan Chatterjee, Yeon-Hee Lee, et al.
Molecular Therapy. Nucleic Acids|October 8, 2024
Large language model to multimodal large language model: A journey to shape the biological macromolecules to biological sciences and medicineManojit Bhattacharya, Soumen Pal, Srijan Chatterjee, et al.
Folia Microbiologica|August 12, 2022
Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscapeManojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Pageof 5